Immuron Limited
IMRN · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | -0.03 | -0.14 | 0.09 |
| FCF Yield | -40.21% | -30.43% | -14.46% | -17.82% |
| EV / EBITDA | -2.36 | -1.52 | -0.09 | 1.38 |
| Quality | ||||
| ROIC | -65.40% | -45.00% | -18.02% | -12.27% |
| Gross Margin | 65.39% | 68.06% | 96.42% | 68.41% |
| Cash Conversion Ratio | 1.18 | 0.85 | 0.66 | 1.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 59.24% | 85.73% | 131.33% | -32.77% |
| Free Cash Flow Growth | -4.36% | -135.57% | 20.56% | -3.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.51 | 2.22 | 5.05 | 7.09 |
| Interest Coverage | -731.63 | -765.72 | -369.75 | -464.08 |
| Efficiency | ||||
| Inventory Turnover | 1.42 | 0.99 | 0.08 | 0.74 |
| Cash Conversion Cycle | 74.80 | 321.39 | 361.45 | -279.25 |